Study to Evaluate the Safety and Efficacy of USL261 (Intranasal Midazolam) in Patients With Seizure Clusters
NCT01390220 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 292
Last updated 2019-10-10
Summary
The purpose of this study is to examine the safety and effectiveness of USL261 for the outpatient treatment of seizure clusters.
Conditions
Interventions
- DRUG
-
USL261
- DRUG
Sponsors & Collaborators
-
UCB Biopharma S.P.R.L.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 12 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-06-30
- Primary Completion
- 2017-03-31
- Completion
- 2017-03-31
Countries
- United States
- Australia
- Canada
- Germany
- Hungary
- Israel
- Italy
- New Zealand
- Poland
- Spain
- Ukraine
Study Locations
More Related Trials
-
Study of Midazolam in Healthy Adults
NCT04679623 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacodynamics of Nasal and Buccal Midazolam Using EEG
NCT01316445 ·Status: TERMINATED ·Phase: PHASE1
-
A Study to Assess the Safety and Efficacy of Lacosamide Versus Placebo (a Pill Without Active Medication) in Patients With Idiopathic Generalised Epilepsy Who Are Already Taking Anti-epileptic Medications
NCT02408523 ·Status: COMPLETED ·Phase: PHASE3
-
Intranasal vs Buccal vs Intramuscular Midazolam for the Home and Emergency Treatment of Acute Seizures
NCT05670509 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Assess Intracerebroventricular (ICV) Delivery of CT-010 in Subjects With Focal Seizures, With Temporal Lobe Onset With or Without Secondary Generalization
NCT04153175 ·Status: TERMINATED ·Phase: PHASE2
-
Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures
NCT01261325 ·Status: COMPLETED ·Phase: PHASE3
-
Intranasal Midazolam Versus Rectal Diazepam for Treatment of Seizures
NCT00326612 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of GWP42006 in People With Focal Seizures - Part B
NCT02365610 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of Seletracetam in Adult Patients With Refractory Partial Onset Seizures
NCT00422110 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
Safety and Efficacy of Lacosamide as Additional Therapy in Patients Suffering From Epileptic Tonic-Clonic Seizures
NCT02408549 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Investigate How Effective, Safe and Tolerable the Drug NBI-921352 is When Used With Anti-seizure Medications in Adults With Focal Onset Seizures
NCT05159908 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Safety and Tolerability of GWP42006 in Healthy Subjects
NCT01918735 ·Status: COMPLETED ·Phase: PHASE1
-
Open-Label Extension Study to Assess the Safety and Seizure Frequency Associated With Lacosamide for Primary Generalized Tonic-Clonic Seizures in Subjects With Epilepsy
NCT01118962 ·Status: COMPLETED ·Phase: PHASE2
-
To Evaluate the Efficacy, Safety, and Tolerability of Intravenous Ganaxolone Added to Standard of Care in Refractory Status Epilepticus (RSE)
NCT05814523 ·Status: WITHDRAWN ·Phase: PHASE3
-
Study of Diazepam Buccal Film Administered in the Interictal and in the Ictal-Periictal States to Adults With Epilepsy
NCT03179891 ·Status: COMPLETED ·Phase: PHASE2
-
Ketamine for the Treatment of Refractory Status Epilepticus
NCT07177235 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
A Clinical Study to Investigate the Efficacy and Safety of Lacosamide as an Add on Therapy in Children With Epilepsy With Partial-onset Seizures
NCT01964560 ·Status: COMPLETED ·Phase: PHASE3
-
Pediatric Dose Optimization for Seizures in Emergency Medical Services
NCT05121324 ·Status: RECRUITING ·Phase: PHASE3
-
Early Surgical Intervention to Treat Epilepsy
NCT00040326 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Tolerability Study of Diazepam Buccal Film (DBF) in Subjects With Epilepsy
NCT03428360 ·Status: COMPLETED ·Phase: PHASE3
-
Brain Infusion of Muscimol to Treat Epilepsy
NCT00005925 ·Status: TERMINATED ·Phase: PHASE1
-
Efficacy and Safety of Adjunctive Zonisamide in Myoclonic Seizures Associated With Idiopathic Generalised Epilepsy
NCT00693017 ·Status: TERMINATED ·Phase: PHASE3
-
Randomized Therapy In Status Epilepticus
NCT04391569 ·Status: COMPLETED ·Phase: PHASE3
-
Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures
NCT01191086 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Lacosamide as Adjunctive Therapy in Subjects ≥1 Month to <4 Years With Partial-onset Seizures
NCT02477839 ·Status: COMPLETED ·Phase: PHASE3